1 results match your criteria: "f Juan F Macias. Hospital Clínico Universitario de Salamanca[Affiliation]"
Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.
Curr Med Res Opin
October 2016
f Juan F Macias. Hospital Clínico Universitario de Salamanca, Salamanca , Spain.
Objective: The RED LEVEL study (REnal Disease: LErcanidipine Valuable Effect on urine protein Losses) directly compares, in an explorative fashion, the effects of lercanidipine + enalapril and amlodipine + enalapril combinations on renal parameters in hypertensive subjects.
Research Design And Methods: This was a 1 year, prospective, multi-center, randomized, open-label, blinded-endpoint (PROBE) study in hypertensive patients with albuminuria.
Main Outcome Measures: Renal function (albuminuria, serum creatinine, creatinine clearance, estimated glomerular filtration rate and proteinuria); blood pressure.